Nektar Therapeutics
Oligomer-phenothiazine conjugates
Last updated:
Abstract:
The invention relates to (among other things) oligomer-phenothiazine conjugates and related compounds. A conjugate of the invention, when administered by any of a number of administration routes, exhibits advantages over un-conjugated phenothiazine compounds.
Status:
Grant
Type:
Utility
Filling date:
11 Oct 2019
Issue date:
22 Dec 2020